<DOC>
	<DOC>NCT00614120</DOC>
	<brief_summary>This trial is conducted in Asia. The trial is designed to compare the effect on glycaemic control of liraglutide or glimepiride added to metformin in subjects with type 2 diabetes</brief_summary>
	<brief_title>Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Type 2 diabetes Subjects diagnosed with type 2 diabetes and treated with one or more oral antidiabetic drugs (OADs) for the last 3 months HbA1c: 7.011.0% (both incl.) for subjects on OAD alone HbA1c: 7.010.0 % (both incl.) for subjects on OAD combination therapy BMI less than 45.0 kg/m^2 Treatment with insulin within the last 3 months prior to the trial Impaired liver or/and renal function Significant cardiovascular disease over the last 6 months Known retinopathy or maculopathy Recurrent major hypoglycaemia or hypoglycaemic unawareness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>